Yubo International Biotech Ltd (YBGJ)
0.935
+0.04
(+4.47%)
USD |
OTCM |
May 24, 16:00
Yubo International Biotech Free Cash Flow (Quarterly): -0.1504M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.1504M |
December 31, 2023 | -0.5584M |
September 30, 2023 | 0.005M |
June 30, 2023 | -0.1529M |
March 31, 2023 | -0.0327M |
December 31, 2022 | -0.6895M |
September 30, 2022 | 0.0155M |
June 30, 2022 | -0.008M |
March 31, 2022 | 0.0414M |
Date | Value |
---|---|
December 31, 2021 | -0.0817M |
September 30, 2021 | 0.0094M |
June 30, 2021 | -0.0591M |
March 31, 2021 | -1.454M |
December 31, 2020 | 0.5237M |
September 30, 2020 | -0.1912M |
June 30, 2020 | 0.211M |
March 31, 2020 | -0.5399M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.454M
Minimum
Mar 2021
0.5237M
Maximum
Dec 2020
-0.1831M
Average
-0.0591M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Meihua International Medical Technologies Co Ltd | -- |
Hologic Inc | 264.40M |
Nuwellis Inc | -2.891M |
Varex Imaging Corp | -2.70M |
Quanterix Corp | -20.67M |